Small Intestinal Bacterial Overgrowth, commonly called SIBO, is an increasingly recognized cause of chronic bloating, gas, abdominal discomfort, and unexplained digestive issues. Many patients in India are treated for acidity, IBS, or food intolerance for years without realizing that the real problem may be excessive bacteria in the small intestine.
SIBO occurs when bacteria that normally live in the large intestine overgrow in the small intestine, where bacterial counts should remain relatively low. This imbalance leads to premature fermentation of food, excessive gas production, nutrient malabsorption, and long-term gut dysfunction.
In cities like Bengaluru, SIBO is often underdiagnosed, particularly in patients who have persistent bloating despite dietary changes or long-term PPI use. Early identification and structured management can significantly improve outcomes.
Under normal conditions, the small intestine contains relatively few bacteria compared to the colon. This allows nutrients to be absorbed efficiently without microbial competition.
SIBO develops when:
The result is excessive fermentation of carbohydrates in the small intestine rather than in the colon.
This leads to production of:
These gases cause bloating, distension, pain, and altered bowel habits.
The body has several defense mechanisms to prevent bacterial overgrowth.
Stomach acid sterilizes ingested microbes before they reach the small intestine.
These secretions have bacteriostatic properties.
This is a fasting motility pattern that sweeps residual food and bacteria downward.
Prevents backflow of colon bacteria into the small intestine.
When these systems fail, bacterial overgrowth can occur.
SIBO is rarely a primary condition. It is usually secondary to an underlying dysfunction.
PPIs reduce stomach acid. Lower acid allows bacteria to survive and colonize the small intestine.
Studies show higher rates of positive hydrogen breath tests in long-term PPI users.
Autonomic neuropathy can impair gut motility, leading to stagnation.
Low thyroid hormone slows intestinal movement.
The vagus nerve regulates gut motility. When compromised, the MMC weakens.
These medications slow gut transit time.
SIBO can be categorized based on gas production.
More commonly associated with diarrhea.
Often linked with constipation. This is technically called Intestinal Methanogen Overgrowth, or IMO.
Methane slows intestinal transit, worsening constipation.
SIBO symptoms overlap with IBS, making diagnosis challenging.
Often worse by evening.
Frequent belching or flatulence.
Especially after meals.
Depends on gas type.
Due to malabsorption.
If symptoms persist despite dietary adjustments, SIBO should be evaluated.
Immediate specialist consultation is required if:
This is the most commonly used non-invasive test.
Procedure:
A rise of 20 ppm hydrogen within 90 minutes suggests SIBO.
Methane levels of 10 ppm or more indicate IMO.
In Bengaluru, hospital-based breath testing provides better supervision and interpretation accuracy.
Dr. Gaurang Ramesh at GutHealthDoctor utilizes structured hydrogen and methane breath testing protocols to ensure diagnostic clarity.
Considered more direct but invasive. Used in complex or unclear cases.
Effective management involves three steps:
Most commonly used due to minimal systemic absorption.
Eradication rates are approximately 60 to 70 percent.
For methane overgrowth, Rifaximin may be combined with Neomycin or Metronidazole.
Reducing fermentable carbohydrates reduces bacterial fuel.
Diet should be phased and supervised, not permanently restrictive.
Recurrence is common if underlying motility dysfunction remains untreated.
Prokinetics may be prescribed to stimulate the MMC.
Meal spacing of 4 to 5 hours without snacking allows proper fasting motility waves.
Regular walking improves transit time.
Consult a gastroenterologist if:
At Arka Anugraha Hospital in South Bengaluru, patients have access to advanced diagnostics and integrative evaluation for recurrent gut dysbiosis.
Early consultation improves long-term remission and reduces unnecessary medication cycles.
During evaluation:
Dr. Gaurang Ramesh integrates conventional gastroenterology with functional gut assessment to identify both bacterial overgrowth and the underlying physiological trigger.
Maintaining gut balance involves:
SIBO is treatable, but prevention of recurrence depends on correcting the root cause.
Small Intestinal Bacterial Overgrowth is a common yet underrecognized cause of chronic bloating and digestive discomfort in India. It sits at the intersection of microbiome imbalance and motility dysfunction.
With proper breath testing, targeted antibiotic therapy, structured dietary modification, and root-cause correction, most patients experience significant improvement.
If you are struggling with persistent bloating gas issues or unexplained digestive symptoms, structured evaluation can provide clarity and relief.
8. Is SIBO permanent?
No. With proper treatment and prevention strategies, it can be resolved.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
